MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, innovatively launches a quantum-enhanced deep convolutional neural network image 3D reconstruction ...
Science Corporation, founded by Neuralink’s first president, Max Hodak, has unveiled a prototype machine to extend the life ...
CES 2026 will feature press conferences from companies like Samsung and AMD, and new breakthroughs in robotics and AI.
IonQ's share price surge overstates future revenue opportunities from its products and services. Click here to read an ...
HONG KONG, Dec. 16, 2025 /PRNewswire/ -- SIGGRAPH Asia 2025 officially opens today at the Hong Kong Convention and Exhibition ...
CAD-Llama: Leveraging Large Language Models for Computer-Aided Design Parametric 3D Model Generation
Abstract: Recently, Large Language Models (LLMs) have achieved significant success, prompting increased interest in expanding their generative capabilities beyond general text into domain-specific ...
Consider these key facts about first-generation (first-gen) college students in the United States, according to the National Association of Student Personnel Administrators (NASPA): At Santa Clara ...
Legacy Perception of the Company Has Led to a Persistently Discounted Valuation as Many Investors Fail to Appreciate the Material Portfolio Transformation That Has Occurred Believes First Industrial ...
Is Gen X actually the greatest generation? In T’s Holiday Issue, we interview many of the most iconic figures from the era, examine why the animated sitcom might be the cohort’s defining art form and ...
Are you expecting a baby in 2026? Your child will be a part of generation Beta. This new generation will live in a world more advanced technologically, socially and scientifically. We're all part of a ...
Persona and Metaphor: ReFantazio director Katsura Hashino claims Japanese role-playing games — often categorized as JRPGs — are entering a new age, dubbing the resurgence as JRPG "3.0." Reflecting on ...
BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced that its first results from the ongoing inMMyCAR study, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results